These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 37641811)
1. Inhibition of the interaction between Hippo/YAP and Akt signaling with ursolic acid and 3'3-diindolylmethane suppresses esophageal cancer tumorigenesis. Meng RY; Li CS; Hu D; Kwon SG; Jin H; Chai OH; Lee JS; Kim SM Korean J Physiol Pharmacol; 2023 Sep; 27(5):493-511. PubMed ID: 37641811 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway. Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656 [TBL] [Abstract][Full Text] [Related]
3. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis. Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988 [TBL] [Abstract][Full Text] [Related]
4. Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer. Kim SH; Jin H; Meng RY; Kim DY; Liu YC; Chai OH; Park BH; Kim SM Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547587 [TBL] [Abstract][Full Text] [Related]
5. YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy. Qian X; He L; Hao M; Li Y; Li X; Liu Y; Jiang H; Xu L; Li C; Wu W; Du L; Yin X; Lu Q Acta Diabetol; 2021 Jan; 58(1):47-62. PubMed ID: 32816106 [TBL] [Abstract][Full Text] [Related]
6. 3,3'-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway. Li XJ; Park ES; Park MH; Kim SM Oncol Rep; 2013 Nov; 30(5):2419-26. PubMed ID: 24008339 [TBL] [Abstract][Full Text] [Related]
7. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade. Meng RY; Jin H; Nguyen TV; Chai OH; Park BH; Kim SM Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768915 [TBL] [Abstract][Full Text] [Related]
8. Regulation of YAP through an Akt-dependent process by 3, 3'-diindolylmethane in human colon cancer cells. Li XJ; Leem SH; Park MH; Kim SM Int J Oncol; 2013 Dec; 43(6):1992-8. PubMed ID: 24100865 [TBL] [Abstract][Full Text] [Related]
9. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2. Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938 [No Abstract] [Full Text] [Related]
10. The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation. Wang W; Huang Q; Chen Y; Huang Z; Huang Y; Wang Y; Qi X; Liu Z; Lu L Pharmacol Res; 2021 Aug; 170():105723. PubMed ID: 34116210 [TBL] [Abstract][Full Text] [Related]
11. C21 steroid-enriched fraction refined from Zhang Y; Li K; Ying Y; Chen B; Hao K; Chen B; Zheng Y; Lyu J; Tong X; Chen X; Wang Y; Zhan Z; Zhang W; Wang Z Oncotarget; 2017 Dec; 8(66):110576-110591. PubMed ID: 29299170 [No Abstract] [Full Text] [Related]
12. Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer. Jeong SH; Kim HB; Kim MC; Lee JM; Lee JH; Kim JH; Kim JW; Park WY; Kim SY; Kim JB; Kim H; Kim JM; Choi HS; Lim DS J Clin Invest; 2018 Mar; 128(3):1010-1025. PubMed ID: 29400692 [TBL] [Abstract][Full Text] [Related]
13. The neuroprotective effects of Insulin-Like Growth Factor 1 via the Hippo/YAP signaling pathway are mediated by the PI3K/AKT cascade following cerebral ischemia/reperfusion injury. Gong P; Zou Y; Zhang W; Tian Q; Han S; Xu Z; Chen Q; Wang X; Li M Brain Res Bull; 2021 Dec; 177():373-387. PubMed ID: 34717965 [TBL] [Abstract][Full Text] [Related]
14. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1. Fan R; Kim NG; Gumbiner BM Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2569-74. PubMed ID: 23359693 [TBL] [Abstract][Full Text] [Related]
15. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway. Wang C; Gu C; Jeong KJ; Zhang D; Guo W; Lu Y; Ju Z; Panupinthu N; Yang JY; Gagea MM; Ng PK; Zhang F; Mills GB Cancer Res; 2017 Apr; 77(7):1637-1648. PubMed ID: 28202507 [TBL] [Abstract][Full Text] [Related]
16. The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis. Zhou X; Yan Z; Hou J; Zhang L; Chen Z; Gao C; Ahmad NH; Guo M; Wang W; Han T; Chang T; Kang X; Wang L; Liang Y; Li X Oncogene; 2024 Feb; 43(7):495-510. PubMed ID: 38168654 [TBL] [Abstract][Full Text] [Related]
17. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway. Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643 [TBL] [Abstract][Full Text] [Related]
18. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways. Zhang LN; Zhao L; Yan XL; Huang YH J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663 [TBL] [Abstract][Full Text] [Related]
19. NGF Signaling Interacts With the Hippo/YAP Pathway to Regulate Cervical Cancer Progression. Wang L; Li J; Wang R; Chen H; Wang R; Wang W; Yang X Front Oncol; 2021; 11():688794. PubMed ID: 34722240 [TBL] [Abstract][Full Text] [Related]